![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
1. Estrone Sulfate
2. Estrone Sulfate, 14c-labeled
3. Estrone Sulfate, 16-(14)c-labeled
4. Estrone Sulfate, Ammonium Salt
5. Estrone Sulfate, Potassium Salt
6. Estrone Sulfate, Sodium Salt
7. Estrone-3-sulfate
8. Evex
9. Oestrone Sulphate
10. Potassium Estrone Sulfate
11. Sodium Estrone Sulfate
1. Sodium Estrone Sulfate
2. Estrone Sodium Sulfate
3. 438-67-5
4. Estrone Sodium Sulphate
5. Estrone 3-sulfate Sodium Salt
6. Conestoral
7. Hyhorin
8. Morestin
9. Estrone Sulfate Sodium
10. Par Estro
11. Estrone Sulfate Sodium Salt
12. Estrone-3-sulfate Sodium Salt
13. Sodium Estrone Sulphate
14. Sodium Estrone 3-sulfate
15. Oestrone-3-sulphate Sodium Salt
16. Estrogenic Substances (conjugated)
17. Estra-1,3,5(10)-trien-17-one, 3-(sulfooxy)-, Sodium Salt
18. 6k6fda543a
19. Chebi:8389
20. 17-oxoestra-1,3,5(10)-trien-3-yl Sodium Sulfate
21. Nsc-18313
22. Estrone Sulfate (sodium)
23. Sodium;[(8r,9s,13s,14s)-13-methyl-17-oxo-7,8,9,11,12,14,15,16-octahydro-6h-cyclopenta[a]phenanthren-3-yl] Sulfate
24. Sodium Estrone-3-sulfate
25. 1,3,5(10)-estratrien-3-ol-17-one Sulphate, Sodium Salt
26. Smr000058772
27. Einecs 207-120-4
28. Nsc 18313
29. Unii-6k6fda543a
30. Conjugated Estrogens: Sodium Estrone Sulfate
31. Estrone3-sulfatesodiumsalt
32. Sodium (8r,9s,13s,14s)-13-methyl-17-oxo-7,8,9,11,12,13,14,15,16,17-decahydro-6h-cyclopenta(a)phenanthren-3-yl Sulfate
33. Sodium (8r,9s,13s,14s)-13-methyl-17-oxo-7,8,9,11,12,13,14,15,16,17-decahydro-6h-cyclopenta[a]phenanthren-3-yl Sulfate
34. Sodium 17-oxoestra-1(10),2,4-trien-3-yl Sulfate
35. Estrone, Hydrogen Sulfate, Sodium Salt
36. Schembl4616
37. Mls000069757
38. Mls001424259
39. Chembl2106240
40. Dtxsid00860005
41. Dtxsid70881181
42. Hms2052j05
43. Hms2232j23
44. Discontinued. See E889070
45. Akos015967195
46. Estrone Sodium Sulfate [vandf]
47. Ccg-101163
48. Hy-113293b
49. Nc00413
50. Estrone Sodium Sulfate [who-dd]
51. Cs-0108249
52. D00312
53. Q4118295
54. Sodium 17-oxoestra-1,3,5(10)-trien-3-yl Sulfate
55. Estrone 3-sulfate Sodium Salt, Stabilized With Tris
56. Estra-1,3,5(10)-trien-17-one 3-(sulfooxy) Sodium Salt
57. Sodium [(8r,9s,13s,14s)-13-methyl-17-oxo-7,8,9,11,12,14,15,16-octahydro-6h-cyclopenta[a]phenanthren-3-yl] Sulfate
Molecular Weight | 372.4 g/mol |
---|---|
Molecular Formula | C18H21NaO5S |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 5 |
Rotatable Bond Count | 2 |
Exact Mass | 372.10073922 g/mol |
Monoisotopic Mass | 372.10073922 g/mol |
Topological Polar Surface Area | 91.9 Ų |
Heavy Atom Count | 25 |
Formal Charge | 0 |
Complexity | 630 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 4 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 2 | |
---|---|
Drug Name | Premarin |
PubMed Health | Conjugated Estrogens (By mouth) |
Drug Classes | Endocrine-Metabolic Agent, Musculoskeletal Agent |
Drug Label | Premarin Intravenous (conjugated estrogens, USP) for injection contains a mixture of conjugated estrogens obtained exclusively from natural sources, occurring as the sodium salts of water-soluble estrogen sulfates blended to represent the average com... |
Active Ingredient | Estrogens, conjugated |
Dosage Form | Tablet; Cream; Injectable |
Route | oral; Injection; Oral; Topical, vaginal |
Strength | 25mg/vial; 0.45mg; 1.25mg; 0.625mg/gm; 0.625mg; 0.9mg; 0.3mg |
Market Status | Prescription |
Company | Wyeth Pharms |
2 of 2 | |
---|---|
Drug Name | Premarin |
PubMed Health | Conjugated Estrogens (By mouth) |
Drug Classes | Endocrine-Metabolic Agent, Musculoskeletal Agent |
Drug Label | Premarin Intravenous (conjugated estrogens, USP) for injection contains a mixture of conjugated estrogens obtained exclusively from natural sources, occurring as the sodium salts of water-soluble estrogen sulfates blended to represent the average com... |
Active Ingredient | Estrogens, conjugated |
Dosage Form | Tablet; Cream; Injectable |
Route | oral; Injection; Oral; Topical, vaginal |
Strength | 25mg/vial; 0.45mg; 1.25mg; 0.625mg/gm; 0.625mg; 0.9mg; 0.3mg |
Market Status | Prescription |
Company | Wyeth Pharms |